Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Raymond Bergan
University of Washington, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Third Coast Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Bergan is inventor of technology that is being studied in this research and which the company in which he has significant financial interests plans to commercialize.
Quantitation of protein interactions in cancer cells
PROJECT NARRATIVE Proteins are functional molecules critical to nearly all cellular processes involved in disease and normal healthy states and are targets of many pharmacological agents. Most molecular therapies result in altered protein structures, activities, and molecular interactions in cells. This project will identify in vivo structural features and molecular interactions that are altered during treatment of cancer cells with a variety of chemotherapies.
Filed on January 04, 2017.
Tell us what you know about Raymond Bergan's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Raymond Bergan”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Raymond Bergan | University of Washington | Conflict of Interest | Third Coast Therapeutics | Value cannot be readily determined |
| Raymond Bergan | University of Washington | Conflict of Interest | Third Coast Therapeutics | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.